Aescap is a life sciences investment firm that manages two funds: Aescap Life Sciences and Aescap Genetics. They invest in innovative biotech companies, focusing on next-generation medical treatments and RNA, gene, and cell therapies. Their target audience includes institutional investors and high-net-worth individuals. Aescap's unique selling proposition is its expertise in selecting transformative biotech companies, aiming for high annual returns while contributing to medical advancements for diseases with unmet needs[1][3].